Business
ALR Technologies Releases Select Results from Market Research on Diabetic Pet Industry; Market Demand High for Innovation
ALR Technologies Releases Select Results from Market Research on Diabetic Pet Industry; Market Demand High for Innovation.
About this update from Alr Technologies Sg Ltd.
[{"type":"text","content":"\n GluCurve is the world’s first continuous glucose monitor (CGM) for diabetic dogs and catsGluCurve eliminates need for manual, costly and cumbersome “glucose curves” that are today’s standard of care2017 AVMA Report shows between 28,000-32,000 veterinary practices in U.S.97% of DVM survey respondents indicated they’d use a pet CGM system to diagnose and manage diabetic dogs and cats as soon as available SINGAPORE, Oct. 21, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to release select results from comprehensive market research conducted by the consulting firm SmartPharma, evaluating the current approach to diabetes diagnosis, glucose monitoring and insulin treatment in cats and dogs. The conclusions speak strongly about the market demand for innovation to modernize the arcane standard of care today, which ALRT interprets as highly favorable for introducing the GluCurve™ Pet CGM (continuous glucose monitoring) as a simple, accurate, reliable and pain-free system to treat the approximately 4.5 million diabetic dogs and cats worldwide. GluCurve™ is the world’s first and only CGM for cats and dogs. Once applied to the pet, it automatically collects blood glucose readings every 5 minutes for up to 14 days. Over the course of 24 hours, 288 data points are transmitted via Bluetooth to the pet owner’s synchronized device and then to the ALRT portal where the data is analyzied and presented to the veterinarian to quickly and effortlessly facilitate optimal care. “The market research included veterinarians from across the United States and ranged from small private practices to large corporate clinics, and the responses were simply fantastic, as they validated our contention that GluCurve™ would fill a large void in animal health care,” commented Sidney Chan, Chairman and CEO of ALR Technologies. “We have developed a turnkey system that eliminates pain points across the complete spectrum of diabetic pet care by bringing cutting edge technology into the companion animal market, a development vets, pets and pet owners can all appreciate. We look forward to the commercial launch of GluCurve™ as the survey indicated that the veterinar...